FORT LAUDERDALE, FL, May 21, 2025 (GLOBE NEWSWIRE) -- Kaida BioPharma (“Kaida” or the “Company”), an early-stage pharma company dedicated to advancing targeted anti-cancer therapies to address hormone ...
Leveraging Northway Biotech's 20+ years of CDMO expertise, Kaida BioPharma is advancing KAD101, a targeted therapy for hormone-driven ovarian cancer Under the terms of the agreement, Northway Biotech ...
Officials at Northway Biotech say they will leverage the company’s expertise to develop a robust manufacturing process for KAD101. This involves Northway’s developing and qualifying analytical methods ...
Appointment aligns Board leadership with Company’s transition to clinical-stage development and advancement of KAD-101 for platinum-resistant ovarian cancer FORT LAUDERDALE, FL, Jan. 22, 2026 (GLOBE ...
Kaida has invested in two agricultural product processing plants which will feature Tomra’s steam peeling and optical sorting machines. The facility in Inner Mongolia will be commissioned in Q2 2017 ...
Appointment aligns Board leadership with Company’s transition to clinical-stage development and advancement of KAD-101 for platinum-resistant ovarian cancer Company advancing KAD-101, a best-in-class, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results